18961-96-1 Usage
General Description
Dichlorophenoxysulfanylidene phosphorane is a highly specific chemical compound. As the name suggests, it contains elements such as phosphorus, sulfur, chlorine, and oxygen. Dichlorophenoxysulfanylidene phosphorane belongs to the class of organophosphorus compounds, which are often used in various sectors, from agriculture to the computer industry, due to their unique properties. Some of these compounds can be harmful or lethal to humans and animals, so their use is often strictly regulated. Specific properties, including the molecular structure, melting point, reactivity, and other similar characteristics of dichlorophenoxysulfanylidene phosphorane, would need to be determined through precise scientific tests. Information about this particular compound's usage or toxicity is scarce, indicating it likely has limited use or is primarily used in specialized fields.
Check Digit Verification of cas no
The CAS Registry Mumber 18961-96-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,9,6 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 18961-96:
(7*1)+(6*8)+(5*9)+(4*6)+(3*1)+(2*9)+(1*6)=151
151 % 10 = 1
So 18961-96-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H5Cl2OPS/c7-10(8,11)9-6-4-2-1-3-5-6/h1-5H
18961-96-1Relevant articles and documents
Hydrogen Bond Donor Catalyzed Cationic Polymerization of Vinyl Ethers
Kottisch, Veronika,Jermaks, Janis,Mak, Joe-Yee,Woltornist, Ryan A.,Lambert, Tristan H.,Fors, Brett P.
supporting information, p. 4535 - 4539 (2020/12/15)
The synthesis of high-molecular-weight poly(vinyl ethers) under mild conditions is a significant challenge, since cationic polymerization reactions are highly sensitive to chain-transfer and termination events. We identified a novel and highly effective h
DEUTERATED NUCLEOSIDE PRODRUGS USEFUL FOR TREATING HCV
-
Paragraph 0297; 0298, (2014/10/29)
Deuterated nucleoside analogs of Formula (I) and the pharmaceutically acceptable salts thereof are provided by this disclosure The variables, e.g., B1, Y, R1, R2, R3, R3′, R4, R5, R6, R7, R8, and R9 carry definitions set forth in the disclosure. Compounds of Formula (I) are deuterated at one or more positions and the deuterium enrichment at each deuterated positions is at least 50%. Compounds and salts of Formula (I) are useful for treating viral infections, including HCV infections.
METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS
-
Paragraph 0056, (2013/10/07)
Disclosed herein are methods of preparing a phosphorothioate nucleotide analog, which are useful in treating diseases and/or conditions such as viral infections.